We are live on
!
Find out more
Loomis, Sayles & Company Portfolio holdings
AUM
$74.3B
1-Year Est. Return
24.01%
This Fund
S&P 500
This Quarter
Est. Return
+26.05%
1 Year Est. Return
+24.01%
3 Year Est. Return
+109.67%
5 Year Est. Return
+145.58%
10 Year Est. Return
+623.12%
AUM
$62.3B
AUM Growth
+$13.8B
(+28%)
Cap. Flow
+$3.01B
Cap. Flow
% of AUM
4.83%
Top 10 Holdings %
Top 10 Hldgs %
42.27%
Holding
775
New
54
Increased
269
Reduced
324
Closed
89
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bank of America Series L
BAC.PRL
|
+$1.47B |
| 2 |
Boeing
BA
|
+$959M |
| 3 |
Walt Disney
DIS
|
+$896M |
| 4 |
Salesforce
CRM
|
+$633M |
| 5 |
Intuitive Surgical
ISRG
|
+$407M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$751M |
| 2 |
Procter & Gamble
PG
|
+$623M |
| 3 |
NVO
Novo Nordisk
NVO
|
+$579M |
| 4 |
Merck
MRK
|
+$440M |
| 5 |
Yum China
YUMC
|
+$153M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.89% |
| 2 | Consumer Discretionary | 16.68% |
| 3 | Healthcare | 12.96% |
| 4 | Communication Services | 12.75% |
| 5 | Financials | 10.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SAFE
176
Safehold
SAFE
$1.15B
| $25.1M | 0.04% |
418,341
| – | – |
|
177
Aecom
ACM
$9.75B
| $24.6M | 0.04% |
655,385
+152,377
| +30% | +$5.46M |
|
178
Genpact
G
$5.76B
| $24.5M | 0.04% |
670,552
-35,022
| -5% | -$1.18M |
|
|
PRMW
179
DELISTED
Primo Water Corporation
PRMW
| $24.4M | 0.04% |
1,777,201
+64,776
| +4% | +$727K |
|
|
MINI
180
DELISTED
Mobile Mini Inc
MINI
| $24.4M | 0.04% |
826,040
+200,981
| +32% | +$5.99M |
|
181
Phreesia
PHR
$773M
| $24.3M | 0.04% |
858,334
+74,536
| +10% | +$1.94M |
|
182
Veracyte
VCYT
$3.8B
| $24.3M | 0.04% |
936,795
+212,522
| +29% | +$5.3M |
|
|
BPMC
183
DELISTED
Blueprint Medicines
BPMC
| $24.1M | 0.04% |
+309,199
| New | +$20.9M |
|
184
Paylocity
PCTY
$7.98B
| $24.1M | 0.04% |
164,984
-14,310
| -8% | -$1.66M |
|
|
ARCE
185
DELISTED
Arco Platform Limited Class A Common Shares
ARCE
| $23.6M | 0.04% |
+541,713
| New | +$25.7M |
|
186
Evertec
EVTC
$1.78B
| $23.4M | 0.04% |
831,370
+72,249
| +10% | +$1.92M |
|
187
Tenable Holdings
TENB
$4.01B
| $23.3M | 0.04% |
+783,163
| New | +$21.3M |
|
|
NUVA
188
DELISTED
NuVasive, Inc.
NUVA
| $23.2M | 0.04% |
416,467
+36,111
| +9% | +$2.09M |
|
189
Churchill Downs
CHDN
$6.12B
| $23.1M | 0.04% |
346,980
-7,900
| -2% | -$450K |
|
|
RETA
190
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $22.9M | 0.04% |
146,783
+12,894
| +10% | +$1.96M |
|
191
iRhythm Holdings
IRTC
$4.2B
| $22.8M | 0.04% |
196,391
+49,219
| +33% | +$5.43M |
|
192
Neurocrine Biosciences
NBIX
$16.6B
| $22.6M | 0.04% |
185,507
+14,362
| +8% | +$1.59M |
|
193
Post Holdings
POST
$3.57B
| $22.6M | 0.04% |
393,274
+40,019
| +11% | +$2.33M |
|
|
MANT
194
DELISTED
Mantech International Corp
MANT
| $22.5M | 0.04% |
328,789
+88,180
| +37% | +$6.49M |
|
|
PPLI
195
People Inc
PPLI
$3.1B
| $22.5M | 0.04% |
389,524
-6,066
| -2% | -$269K |
|
196
Prosperity Bancshares
PB
$8.89B
| $22.4M | 0.04% |
377,358
-5,118
| -1% | -$295K |
|
|
EPZM
197
DELISTED
Epizyme, Inc
EPZM
| $22.3M | 0.04% |
1,386,996
+120,452
| +10% | +$2.1M |
|
198
First American
FAF
$7.58B
| $22.2M | 0.04% |
462,040
-12,552
| -3% | -$593K |
|
199
RB Global
RBA
$17.5B
| $21.9M | 0.04% |
536,288
+41,700
| +8% | +$1.71M |
|
200
Artivion
AORT
$1.32B
| $21.5M | 0.03% |
1,122,401
+97,510
| +10% | +$2.07M |
|
Similar funds
CBU
BC
Loomis, Sayles & Company's Q2 2020 Portfolio in Review
As of Q2 2020, Loomis, Sayles & Company held 775 positions worth $62.3B, up 28% from $48.5B the previous quarter. Its ten largest holdings account for 42% of the portfolio.
Loomis, Sayles & Company deployed $3.01B of net new capital in Q2 2020, opening 54 new positions and adding to 269 existing holdings. Its largest new stake was Dropbox: 3,912,402 shares worth $85.2M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 24% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Amgen, an estimated $751M trimmed.
- Loomis, Sayles & Company's largest Q2 2020 buy was Dropbox: 3,912,402 shares worth $85.2M.
- Loomis, Sayles & Company added most to Bank of America Series L in Q2 2020, an estimated $1.47B increase.
- Loomis, Sayles & Company's biggest Q2 2020 reduction was Amgen, cutting an estimated $751M.
- Loomis, Sayles & Company fully exited Broadcom Inc. 8.00% Mandatory Convertible Preferred Stock, Series A in Q2 2020, selling an estimated $32.2M.
- Loomis, Sayles & Company's ten largest holdings make up 42% of its $62.3B portfolio in Q2 2020.
- Loomis, Sayles & Company opened 54 new positions and closed 89 in Q2 2020.
- Loomis, Sayles & Company's portfolio value rose 28% quarter-over-quarter to $62.3B.
Based on Loomis, Sayles & Company's 13F filing for Q2 2020, filed 14 Aug 2020.